ReAIX Chem
Drug substance · Small molecules
Optimizes reaction conditions for API synthesis and ranks the next experiments to run.
- Solvent, catalyst and ligand selection
- Temperature and stoichiometry optimization
- Yield and impurity optimization
- Process safety and risk assessment
- Cost of goods (COGS) evaluation
Request a trial →
ReAIX Bio
Drug substance · Biologics
From antibody developability and sequence to upstream process development and scale-up, with AI models that replace slow simulations.
- Antibody developability screening and assessment
- Antibody sequence optimization
- Upstream process development with AI predictions
- AI agent–guided optimization of scale-up parameters
- Physics-informed AI for CFD analysis
Request a trial →
ReAIX Formulation
Drug product · Formulation
Predicts API–excipient compatibility and formulation stability before lab work begins. Currently focused on small-molecule drug products.
- API–excipient compatibility screening
- Stability prediction
- Pharmacokinetic (PK) prediction models, in development
- Faster formulation development
- AI-assisted literature and data review
Request a trial →